Page 17 - Bioterrorism
P. 17

16


               Both these influenza proteins, based on the genetic sequences released Friday May 1st by the U.S.
               Centers of Disease Control (CDC),  share their closest genetic identity with turkey (avian) and pig
               (swine) strains from multiple continents including North America as well as Asia. Even the closest
               matches indicate 5% previously unidentified genetic material.


               I submit this evidence, coupled with the lack of the presence of this virus at the pig farm near the
               proposed CDC's "patient zero" (a 5 year old from La Gloria, 80km away from the pig farm in
               Perote, Mexico), shows that the origin of the flu outbreak remains unidentified at this time, and
               cannot be ascribed to Mexican or North American swine.


               Furthermore, I submit that since 5% of both these influenza A RNA sequences share no known
               homology in any public databases (in addition to the avian/swine hybrid nature of both these
               critical genes), that we must seriously consider a laboratory origin for this virus.


               Future research that may be promising includes identifying critical SNPs, especially in the PB2
               and the NS1 coding regions which may be markers for evolution of pathogen virulence, and
               should be closely monitored.  The hemagglutinin protein should also be monitored for acquisition
               of a poly-basic amino acid site which would give the virus pantrophic properties as in the 1918
               pandemic. “(Alexander S Jones)


               50. The World Health Organization on May 11 said leading vaccine producers including Baxter,
               Novartis, GlaxoSmithKline and Sanofi-Aventis had requested “wild type virus” samples of the A
               (H1N1) or swine flu  virus. MedImmune, which is now part of AstraZeneca, Baxter, CSL and
               Solvay are also being sent samples, as are smaller developers Microgen, Nobilon International,
               Omnivest Vaccines and Vivaldi. The WHO is co-coordinating scientific discussions over the virus,
               and has said that, within the next few weeks, it is likely to make a recommendation on whether
               and how to produce a pandemic vaccine.

               51. Latest Pandemic Time Estimates, based on Los Alamos Flu Simulation
               http://www.lanl.gov/news/images/bird4x3red.mov

               by Alexander S Jones


               *using baseline U.S. zero day of April 20th, 2009


               Monday April 20        Day  1
               Monday April 27        Day  7
               Monday May    4        Day 14
               Monday May   11        Day 21
               Monday May   18        Day 28
               Monday May   25        Day 35
               Monday June   1        Day 42
               Monday June   8        Day 49   <--  WHO Declares Phase 6  (by Day 53, aka by Friday June 12th)
               Monday June  15        Day 56
               Monday June  22        Day 63  <-- Cases Go Exponential   (by Day 60, aka by Friday June 19th)
               Monday June  29        Day 70
               Monday July   6        Day 77
               Monday July  13        Day 84
               Tuesda July  14        Day 85
               Wednes July  15        Day 86
               Thursd July  16        Day 87  <-- Wave 1 Outbreak Peaks  (by Day 87, aka by Thursday July 16th)
   12   13   14   15   16   17   18   19   20   21   22